PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 19 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,583,000 | +0.6% | 1,950,000 | 0.0% | 0.00% | – |
| Q2 2020 | $1,573,000 | +5.6% | 1,950,000 | 0.0% | 0.00% | – |
| Q1 2020 | $1,489,000 | +7.9% | 1,950,000 | 0.0% | 0.00% | – |
| Q4 2019 | $1,380,000 | -2.1% | 1,950,000 | 0.0% | 0.00% | – |
| Q3 2019 | $1,410,000 | +7.6% | 1,950,000 | 0.0% | 0.00% | – |
| Q2 2019 | $1,311,000 | – | 1,950,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cohanzick Management, LLC | 25,112,000 | $25,557,982 | 22.10% |
| Westchester Capital Management, LLC | 8,267,000 | $8,308,536 | 0.24% |
| MACQUARIE GROUP LTD | 5,359,000 | $5,386,000 | 0.01% |